Quote:

---

Here’s an example of the deals for MediSource and Pantheon being far too beneficial to their CEO along with his consulting agreement:

“Travis Bird terminated the Consulting Agreement on July 20, 2020 and Travis Bird is no longer entitled to further commissions from future net sales. For the year ended July 31, 2020, Travis earned $1,404,915 under this agreement and has been paid $773,366, leaving a balance of $631,549.”

Generex needed that money for far better reasons.


Read More: https://investorshangout.com/post/view?id=596...z7uqkNWhmp.

---

Look at much Travis received from Generex in the first seven months of calendar 2020. That is insane as his companies earned no revenue after shareholders were promised they were profitable. There’s more info on him too. I once found a highly negative report on him and his companies Generex ignorantly (at best) acquired that claimed his previous reported revenue was tied to Veneto’s legacy company, the one raided by the FBI for fraud. So here’s a little trail if any of the investigators peak in here.